Quipt Home Medical Corp. (NASDAQ:QIPT – Free Report) – Equities researchers at Leede Financial issued their FY2027 EPS estimates for shares of Quipt Home Medical in a research report issued on Tuesday, February 11th. Leede Financial analyst D. Loe expects that the company will post earnings of ($0.10) per share for the year. The consensus estimate for Quipt Home Medical’s current full-year earnings is ($0.05) per share.
Quipt Home Medical (NASDAQ:QIPT – Get Free Report) last announced its quarterly earnings results on Monday, February 10th. The company reported ($0.03) earnings per share (EPS) for the quarter. Quipt Home Medical had a negative net margin of 2.66% and a negative return on equity of 6.18%.
Quipt Home Medical Trading Down 1.0 %
Insider Activity at Quipt Home Medical
In related news, VP Patrick Dennis Gamble acquired 17,000 shares of the business’s stock in a transaction that occurred on Thursday, December 26th. The shares were acquired at an average cost of $2.45 per share, with a total value of $41,650.00. Following the transaction, the vice president now owns 40,057 shares of the company’s stock, valued at $98,139.65. The trade was a 73.73 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 13.40% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Quipt Home Medical
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. SG Americas Securities LLC bought a new stake in Quipt Home Medical during the 3rd quarter worth about $44,000. Atom Investors LP bought a new stake in Quipt Home Medical during the 3rd quarter worth about $51,000. XTX Topco Ltd bought a new stake in Quipt Home Medical during the 3rd quarter worth about $54,000. Wells Fargo & Company MN lifted its position in Quipt Home Medical by 30.9% during the 4th quarter. Wells Fargo & Company MN now owns 23,851 shares of the company’s stock worth $73,000 after buying an additional 5,625 shares in the last quarter. Finally, TD Waterhouse Canada Inc. lifted its position in Quipt Home Medical by 83.4% during the 4th quarter. TD Waterhouse Canada Inc. now owns 27,435 shares of the company’s stock worth $76,000 after buying an additional 12,479 shares in the last quarter. 42.85% of the stock is owned by institutional investors.
Quipt Home Medical Company Profile
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.
See Also
- Five stocks we like better than Quipt Home Medical
- P/E Ratio Calculation: How to Assess Stocks
- NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Up 50% in January, Twilio’s Pullback Is the Time to Buy
- What Are Growth Stocks and Investing in Them
- Watch These 3 Stocks—High Short Interest and Big Upside Potential
Receive News & Ratings for Quipt Home Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quipt Home Medical and related companies with MarketBeat.com's FREE daily email newsletter.